These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 38531362)
21. Quantitative MRI of skeletal muscle in a cross-sectional cohort of patients with spinal muscular atrophy types 2 and 3. Otto LAM; van der Pol WL; Schlaffke L; Wijngaarde CA; Stam M; Wadman RI; Cuppen I; van Eijk RPA; Asselman FL; Bartels B; van der Woude D; Hendrikse J; Froeling M NMR Biomed; 2020 Oct; 33(10):e4357. PubMed ID: 32681555 [TBL] [Abstract][Full Text] [Related]
22. Spinal muscular atrophy with respiratory distress type 1 (SMARD1). Kaindl AM; Guenther UP; Rudnik-Schöneborn S; Varon R; Zerres K; Schuelke M; Hübner C; von Au K J Child Neurol; 2008 Feb; 23(2):199-204. PubMed ID: 18263757 [TBL] [Abstract][Full Text] [Related]
23. Real-Life Outcome After Gene Replacement Therapy for Spinal Muscular Atrophy: A Multicenter Experience. Tokatly Latzer I; Sagi L; Lavi R; Aharoni S; Bistritzer J; Noyman I; Ginsburg M; Lev-Or A; Katzenellenbogen S; Nevo Y; Fattal-Valevski A Pediatr Neurol; 2023 Jul; 144():60-68. PubMed ID: 37149951 [TBL] [Abstract][Full Text] [Related]
24. Motor unit number index: A potential electrophysiological biomarker for pediatric spinal muscular atrophy. Boulay C; Delmont E; Audic F; Chabrol B; Attarian S Muscle Nerve; 2021 Oct; 64(4):445-453. PubMed ID: 34255873 [TBL] [Abstract][Full Text] [Related]
26. Mitochondrial myopathy simulating spinal muscular atrophy. Pons R; Andreetta F; Wang CH; Vu TH; Bonilla E; DiMauro S; De Vivo DC Pediatr Neurol; 1996 Sep; 15(2):153-8. PubMed ID: 8888051 [TBL] [Abstract][Full Text] [Related]
27. Clinical outcome measures in spinal muscular atrophy. Montes J; Gordon AM; Pandya S; De Vivo DC; Kaufmann P J Child Neurol; 2009 Aug; 24(8):968-78. PubMed ID: 19509409 [TBL] [Abstract][Full Text] [Related]
28. Clinical and mutational characteristics of spinal muscular atrophy with respiratory distress type 1 in The Netherlands. Stalpers XL; Verrips A; Poll-The BT; Cobben JM; Snoeck IN; de Coo IF; Brooks A; Bulk S; Gooskens R; Fock A; Verschuuren-Bemelmans C; Sinke RJ; de Visser M; Lemmink HH Neuromuscul Disord; 2013 Jun; 23(6):461-8. PubMed ID: 23566544 [TBL] [Abstract][Full Text] [Related]
29. Lumbosacral ventral spinal nerve root atrophy identified on MRI in a case of spinal muscular atrophy type II. Smith G; Bell SK; Sladky JT; Kang PB; Albayram MS Clin Imaging; 2019; 53():134-137. PubMed ID: 30340076 [TBL] [Abstract][Full Text] [Related]
31. Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study. Kariyawasam DS; D'Silva AM; Sampaio H; Briggs N; Herbert K; Wiley V; Farrar MA Lancet Child Adolesc Health; 2023 Mar; 7(3):159-170. PubMed ID: 36669516 [TBL] [Abstract][Full Text] [Related]
32. Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3. Wolfe A; Stimpson G; Ramsey D; Coratti G; Dunaway Young S; Mayhew A; Pane M; Rohwer A; Muni Lofra R; Duong T; O'Reilly E; Milev E; Civitello M; Sansone VA; D'Amico A; Bertini E; Messina S; Bruno C; Albamonte E; Mazzone E; Main M; Montes J; Glanzman AM; Zolkipli-Cunningham Z; Pasternak A; Marini-Bettolo C; Day JW; Darras BT; De Vivo DC; Baranello G; Scoto M; Finkel RS; Mercuri E; Muntoni F; J Neuromuscul Dis; 2024; 11(3):665-677. PubMed ID: 38427497 [TBL] [Abstract][Full Text] [Related]
33. The predictive value of achieved motor milestones assessed in 441 patients with infantile spinal muscular atrophy types II and III. Rudnik-Schöneborn S; Hausmanowa-Petrusewicz I; Borkowska J; Zerres K Eur Neurol; 2001; 45(3):174-81. PubMed ID: 11306862 [TBL] [Abstract][Full Text] [Related]
34. Perspectives on clinical trials in spinal muscular atrophy. Swoboda KJ; Kissel JT; Crawford TO; Bromberg MB; Acsadi G; D'Anjou G; Krosschell KJ; Reyna SP; Schroth MK; Scott CB; Simard LR J Child Neurol; 2007 Aug; 22(8):957-66. PubMed ID: 17761650 [TBL] [Abstract][Full Text] [Related]
35. Decreased expression of full-length mRNA for cBCD541 does not correlate with spinal muscular atrophy phenotype severity. Nishio H; Ishikawa Y; Lee MJ; Fujii M; Kanda F; Jinnai K; Takahashi K; Takeshima Y; Wada H; Takada S; Nakamura H; Matsuo M; Sumino K Neurology; 1997 May; 48(5):1266-70. PubMed ID: 9153454 [TBL] [Abstract][Full Text] [Related]
36. Guidance on Gene Replacement Therapy in Spinal Muscular Atrophy: A Canadian Perspective. Oskoui M; Gonorazky H; McMillan HJ; Dowling JJ; Amin R; Gagnon C; Selby K Can J Neurol Sci; 2022 May; 49(3):398-401. PubMed ID: 34082851 [No Abstract] [Full Text] [Related]
37. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene. Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550 [TBL] [Abstract][Full Text] [Related]